Healthcare
Glenmark Pharmaceuticals Limited (GLENMARK)
Glenmark Pharmaceuticals Limited (GLENMARK) is an NSE-listed Healthcare company. latest close ₹2,311, 1-day return +0.7%, 1-week return -5.3%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 5 Oct 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹2,311
- 1-day return
- +0.7%
- 1-week return
- -5.3%
- 1-month return
- -5.2%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 46.0
- ADX (14)
- 36.6
- ROC 10
- -5.7%
- vs 52W high
- -8.9%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹65,787 Cr
- P/E
- 36.6
- P/B
- 6.26
- ROE
- —
- D/E
- 5.65
- Net margin
- 10.1%
- Rev. growth YoY
- 28.5%
- Div. yield
- 32.0%
- 52W high
- ₹2,537.6
- 52W low
- ₹1,792.6
- EPS (TTM)
- ₹63.64
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +0.7%
Latest 1-day price change versus the previous close.
- signal
1-week return -5.3%
Price change over the last five trading sessions.
- signal
ADX(14) 37 — trend in force
ADX above 25 usually means a directional move is underway.
News & screener mentions
Recent QUANTSCASE daily posts that listed GLENMARK.
No recent screener posts mentioned GLENMARK yet. New daily posts will show up here automatically.
